RNAC
Cartesian Therapeutics Inc.
$6.14
-$0.14(-2.23%)
40
Overall
40
Value
40
Tech
--
Quality
Market Cap
$166.48M
Volume
118.63K
52W Range
$5.60 - $15.57
Target Price
$35.57
EPS Estimates Overview
| Current Quarter | $-0.84 | Next Quarter | $-0.89 |
| Current Year | $-3.26 | Next Year | $-3.73 |
| QoQ Growth | -6.0% | YoY Growth | -14.4% |
| 3Y EPS CAGR | +12.1% | Target Price | $35.57 |
| Consensus | Buy | Upside | +479.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $6.14 | -2.2% | 118.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW